2.195
Inmune Bio Inc (INMB) 最新ニュース
Can INmune Bio Inc. hit a new high this month2025 Breakouts & Breakdowns & Intraday High Probability Alerts - Newser
Can INmune Bio Inc. recover in the next quarterTrade Analysis Report & Verified Entry Point Signals - Newser
Analyzing INmune Bio Inc. with multi timeframe chartsTrade Volume Summary & Weekly High Momentum Picks - Newser
Is it too late to sell INmune Bio Inc.Share Buyback & High Accuracy Trade Alerts - Newser
Can machine learning forecast INmune Bio Inc. recoveryGap Up & Expert Curated Trade Setups - Newser
What’s next for INmune Bio Inc. stock priceProduct Launch & Technical Buy Zone Confirmation - Newser
What’s the recovery path for long term holders of INmune Bio Inc.Quarterly Portfolio Review & Safe Swing Trade Setups - Newser
INmune Bio Inc.’s volatility index tracking explainedJuly 2025 Market Mood & Real-Time Volume Trigger Notifications - Newser
What candlestick patterns are forming on INmune Bio Inc.Earnings Recap Report & Real-Time Volume Triggers - Newser
Will earnings trigger a reversal in INmune Bio Inc.2025 EndofYear Setup & Safe Swing Trade Setups - Newser
Visual analytics tools that track INmune Bio Inc. performanceMarket Activity Recap & Weekly Sector Rotation Insights - Newser
INmune Bio's US$7.7m Market Cap Fall Books Insider Losses - simplywall.st
Is INmune Bio Inc. stock bottoming outBond Market & Community Shared Stock Ideas - Newser
Will a bounce in INmune Bio Inc. offer an exitJuly 2025 Gainers & Safe Capital Growth Stock Tips - Newser
Published on: 2025-08-25 02:32:06 - Newser
Is now a turning point for INmune Bio Inc.Stop Loss & Stepwise Swing Trade Plans - Newser
Evaluating INmune Bio Inc. with trendline analysisEarnings Risk Summary & Advanced Technical Analysis Signals - Newser
Should you wait for a breakout in INmune Bio Inc.2025 Big Picture & Real-Time Volume Surge Alerts - Newser
Using Bollinger Bands to evaluate INmune Bio Inc.Market Risk Report & AI Powered Market Trend Analysis - Newser
Analyzing net buyer seller activity in INmune Bio Inc.Day Trade & Weekly Return Optimization Plans - Newser
Can INmune Bio Inc. ride the EV wave2025 Price Momentum & Community Consensus Trade Signals - theviewers.co.kr
Is INmune Bio Inc. still worth holding after the dipWeekly Stock Recap & Stepwise Trade Signal Guides - Newser
Detecting price anomalies in INmune Bio Inc. with AIPortfolio Performance Summary & Community Trade Idea Sharing - Newser
Can INmune Bio Inc. Regain Lost Ground This QuarterEarnings Recap Summary & Growth Focused Entry Point Reports - beatles.ru
Real Time Data Flags Unusual Activity in INmune Bio Inc.Volume Spike & Real-Time Buy Zone Alerts - beatles.ru
Competitive Positioning of INmune Bio Inc.: Is It Leading or Lagging2025 Year in Review & Daily Stock Trend Reports - Newser
Intraday pattern recognizer results for INmune Bio Inc.Market Weekly Review & Weekly Stock Performance Updates - Newser
INmune Bio Inc. stock trend forecastEarnings Recap Report & Weekly Top Gainers Alerts - Newser
Is INmune Bio Inc. stock entering bullish territory2025 Risk Factors & Free Safe Entry Trade Signal Reports - Newser
What makes INmune Bio Inc. stock price move sharply2025 Sector Review & Proven Capital Preservation Methods - Newser
Is INmune Bio Inc. stock overhyped or has real potential2025 Technical Overview & Real-Time Buy Signal Alerts - Newser
INmune Bio Inc. Announces Second Quarter 2025 Results, Provides Business Update and Announces Management Changes - ADVFN Brasil
Intraday Charts Show Spike in INmune Bio Inc. ActivityJuly 2025 Setups & Free Safe Capital Growth Stock Tips - beatles.ru
Can Traders Expect Breakout From INmune Bio Inc. This WeekWeekly Trading Summary & AI Powered Buy/Sell Recommendations - 선데이타임즈
Inmune Bio Inc. shares fall 1.24% premarket after Climb Bio reports financial results and Generation Bio announces new data. - AInvest
INmune Bio Inc. Recovery Potential Based on Technical ToolsChart-Based Trade Entries Gain Analyst Support - beatles.ru
Undervalued Innovators in Biotech: Assessing Altimmune and INmune Bio's High-Risk, High-Reward Potential - AInvest
Inmune Bio’s Earnings Call: Progress Amid Challenges - TipRanks
Inmune Bio Inc. shares fall 2.71% intraday as Climb Bio reports financial results and trial updates. - AInvest
Inmune Bio: Strategic Position and Growth Potential Amid Leadership Change and Promising Pipeline - TipRanks
INmune Bio, Inc. (NASDAQ:INMB) Q2 2025 Earnings Call Transcript - Insider Monkey
Why INmune Bio Inc. stock attracts strong analyst attentionSmart Chart Forecasting with AI Algorithms - Newser
INmune Bio outlines CORDStrom BLA and MAA filings targeted for mid-2026 as CEO transition highlights strategic shift - MSN
Is INmune Bio (NASDAQ:INMB) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
INmune Bio CEO Change and Strategic Shift: Core Therapeutic Areas Focus with Potential 199% Price Upside - AInvest
INmune Bio Sets Mid-2026 Timeline for BLA and MAA Filings Amid CEO Transition - AInvest
Earnings call transcript: INmune Bio Q2 2025 reveals wider losses, stock tumbles - Investing.com Nigeria
Earnings call transcript: INmune Bio Q2 2025 reveals wider losses, stock tumbles By Investing.com - Investing.com South Africa
Inmune Bio Inc. shares fall 14.69% premarket after missing primary cognitive endpoints in MINDFuL phase 2 trial. - AInvest
大文字化:
|
ボリューム (24 時間):